Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cell Analysis Software Speeds Search for Potential Eye Cancer Treatment

By LabMedica International staff writers
Posted on 27 Feb 2012
A new cell tracing algorithm has quickened the discovery of an important, previously unknown role for the tumor suppressor gene Rb, which, when abnormally inactivated, is the probable trigger of the aggressive childhood cancer retinoblastoma.

Intensive efforts are being made to identify and characterize the roles of Rb in eye development, but studies have been greatly hampered by limitations of technology available for finding retinal anomalies at the cellular level.

A major limitation has now been removed by the specialized cell tracing, image analysis program developed for a study of the Rb gene published December 27, 2012, in the journal Proceedings of the National Academy of Sciences of the USA (PNAS). More...
The program allowed researchers to analyze thousands of cells instead of just a few dozen. It could also be used as the basis for developing algorithms specialized for analyzing morphological changes in large numbers of other neurons and other cell types.


"Our paper shows that horizontal neurons known to be deficient in this gene exhibited abnormalities in the way their connecting dendrites were organized after a certain number of days after birth," said author Ryan Kerekes, PhD, of the Department of Energy's Oak Ridge National Laboratories (ORNL; Oak Ridge, TN, USA).

The study, led by senior author Michael A. Dyer, PhD, was a collaborative effort among investigators at ORNL, University of Tennessee (UT) at Knoxville (USA), UT at Memphis (USA), St. Jude Children Research Hospital (Memphis, TN, USA), and the Universidade Federal do Rio de Janeiro (Rio de Janeiro, Brazil).

Dr. Kerekes and ORNL team members Dr. Shaun Gleason and Dr. Mahmut Karakaya developed the computer program and automated tool that traces the very complex and intricate dendritic arbor. This allowed scientists to draw a line along each branch in the neuron's tree of connectors so the branch can be measured in terms of length, angle, and other parameters.

"Previously, this was a very time-consuming and labor-intensive process," Kerekes said. "Existing commercial software tools were not tuned to this particular data and, as a result, produced too many tracing errors."

As a result, only a handful of cells could be analyzed in sufficient detail, according to Kerekes, who noted that the ORNL tracing algorithms achieves the level of accuracy required to analyze thousands of developing neurons.

Related Links:
Oak Ridge (US) National Laboratories
University of Tennessee, Knoxville
Universidade Federal do Rio de Janeiro



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.